[Coagulation and fibrinolysis studies in viable newborn infants suffering from critical hyperbilirubinemia].
D000017:ABO Blood-Group System; D001663:Bilirubin / Q000097:blood; D001769:Blood; D001777:Blood Coagulation; D001779:Blood Coagulation Factors / Q000032:analysis; D005078:Exchange Transfusion, Whole Blood; D005341:Fibrinolysin / Q000032:analysis; D005342:Fibrinolysis; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000097:blood* / Q000201:enzymology / Q000628:therapy; D010958:Plasminogen / Q000097:blood; D011517:Prothrombin Time; D012204:Rh-Hr Blood-Group System; D013916:Thrombelastography; D013917:Thrombin / Q000032:analysis; D014470:Umbilical Cord
D000017:ABO Blood-Group System; D001779:Blood Coagulation Factors; D012204:Rh-Hr Blood-Group System; D010958:Plasminogen; D013917:Thrombin; D005341:Fibrinolysin; D001663:Bilirubin
Gerinnungs- und Fibrinolyseuntersuchungen bei lebensfrischen Reifgeborenen mit kritischer Hyperbilirubinämie.